{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:36:37Z","timestamp":1791236197663,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Arthritis Foundation Innovative Research Award"},{"name":"RRF Disease Targeted Research Award"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AR063676"],"award-info":[{"award-number":["AR063676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jaut.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T09:21:24Z","timestamp":1459761684000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-6322","authenticated-orcid":false,"given":"Geraldine","family":"Cambridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Lahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fairhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sokolove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.03.010_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/sji.12265","article-title":"Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination","volume":"81","author":"Ahlin","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2016.03.010_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/rheumatology\/keh414","article-title":"Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.03.010_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.autrev.2005.04.018","article-title":"Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor","volume":"4","author":"Vander Cruyssen","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.03.010_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02686078","article-title":"The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects","volume":"32","author":"Wiik","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2016.03.010_bib5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","article-title":"Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib6","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2005.040659","article-title":"Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis","volume":"65","author":"Nielen","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib8","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/art.37911","article-title":"Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients","volume":"65","author":"Barra","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/annrheumdis-2013-203915","article-title":"Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 \u2018shared epitope\u2019 alleles","volume":"74","author":"Wagner","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib10","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.jaut.2016.03.010_bib11","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.010_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/1744666X.2013.857274","article-title":"The case for measuring antibodies to specific citrullinated antigens","volume":"9","author":"Montgomery","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.03.010_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/annrheumdis-2012-201484","article-title":"Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein\/peptide antibody fine specificity profile","volume":"72","author":"Lundberg","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib14","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.03.010_bib15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/ard.2010.148759","article-title":"Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries","volume":"70","author":"Chatzidionysiou","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","article-title":"Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis","volume":"72","author":"Isaacs","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.03.010_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/ard.2007.080960","article-title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response","volume":"67","author":"Thurlings","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.2009.109041","article-title":"Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis","volume":"69","author":"Thurlings","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-202893","article-title":"Circulating plasmablasts\/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis","volume":"72","author":"Kerkman","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.12.002","article-title":"The effect of B cell depletion therapy on serological evidence of B cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment","volume":"50","author":"Cambridge","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.03.010_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3899\/jrheum.140022","article-title":"Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses","volume":"41","author":"Silverman","year":"2014","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.010_bib23","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/ard.2010.131326","article-title":"B\u00a0cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B cell depletion therapy","volume":"69","author":"de la Torre","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib24","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar3383","article-title":"Novel multiplex technology for diagnostic characterization of rheumatoid arthritis","volume":"13","author":"Chandra","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.010_bib25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib28","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar3770","article-title":"Induction of long-term B cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity","volume":"14","author":"Teng","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.010_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-207259.25","article-title":"Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis","author":"Kerkman","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib30","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.03.010_bib31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A\u00a0single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.jaut.2016.03.010_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1600-6143.2011.03833.x","article-title":"In\u00a0vitro effects of rituximab on the proliferation, activation and differentiation of human B cells","volume":"12","author":"Kamburova","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.jaut.2016.03.010_bib33","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/art.39167","article-title":"Internalization of rituximab and the efficiency of B cell depletion in rheumatoid arthritis and systemic lupus erythematosus","volume":"67","author":"Reddy","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.010_bib34","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib35","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/rheumatology\/keu160","article-title":"Predictive value of ACR core set parameters for the development of rheumatoid arthritis in patients with positive anti-cyclic citrullinated peptide antibodies and undifferentiated arthritis","volume":"53","author":"Meric de Bellefon","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.03.010_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke","volume":"70","author":"Kallberg","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib38","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.39170","article-title":"Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis","volume":"67","author":"Svard","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.03.010_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/annrheumdis-2012-202701","article-title":"The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis?","volume":"73","author":"de Pablo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.03.010_bib40","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.03.010_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imlet.2013.04.007","article-title":"Why do we need IgM memory B cells?","volume":"152","author":"Capolunghi","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2016.03.010_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1196\/annals.1358.014","article-title":"Human B cell tolerance and its failure in rheumatoid arthritis","volume":"1062","author":"Samuels","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.03.010_bib43","doi-asserted-by":"crossref","first-page":"e107513","DOI":"10.1371\/journal.pone.0107513","article-title":"Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis","volume":"9","author":"Cambridge","year":"2014","journal-title":"Plos One"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:13:07Z","timestamp":1760256787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":43,"alternative-id":["S0896841116300233"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.03.010","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}